Registration - In-house Corporation

Idorsia Pharmaceuticals Canada Ltd / Ron Morcos, General Manager Canada

Registration Information

In-house Corporation name: Idorsia Pharmaceuticals Canada Ltd
Responsible Officer Name: Ron Morcos, General Manager Canada
Initial registration start date: 2024-04-03
Registration status: Active
Registration Number: 957685-377646

Associated Communications

Total Number of Communication Reports: 11

Monthly communication reports in the last 6 months: 11

Version 1 of 1 (2024-04-03 to present)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Economic Development, Health, Labour, Research and Development, Science and Technology	Draw attention to Chronic Insomnia's impact on the burden of health and the economy in Canada. Elevating sleep to be recognized as a pillar of health in Canada	Policies or Program, Legislative Proposal, Bill or Resolution

Subject matters added through a monthly communication report

Aboriginal Affairs
Agriculture
Budget
Employment and Training
Industry
International Trade
Small Business
Transportation

Communication Techniques

Written communication
Oral communication

Government Institutions

Agriculture and Agri-Food Canada (AAFC)
Canada Economic Development for Quebec Regions
Canada Foundation for Innovation
Canadian Centre for Occupational Health and Safety (CCOHS)
Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC)
Employment and Social Development Canada (ESDC)
Federal Economic Development Agency for Northern Ontario
Federal Economic Development Agency for Southern Ontario (FedDev)
Finance Canada (FIN)
Financial Consumer Agency of Canada (FCAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Office of the Procurement Ombudsman (OPO)
Patented Medicine Prices Review Board (PMPRB)
Prairies Economic Development Canada (PrairiesCan)
Prime Minister's Office (PMO)
Public Health Agency of Canada (PHAC)
Public Safety Canada (PS)
Public Service Labour Relations Board (PSLRB)
Senate of Canada
Statistics Canada (StatCan)
Transportation Safety Board of Canada (TSB)
Transport Canada (TC)
Veterans Affairs Canada (VAC)
Women and Gender Equality (WAGE)

In-house Corporation Details

Description of activities

Pharmaceutical Sales, Distribution, Research and Development, Clinical trials

Responsible officer name and position during the period of this registration

Ron Morcos, General Manager Canada

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
6500 Trans-Canada Hwy
Suite 220
Pointe Claire, QC H9R 0A5
Canada

Telephone number: 905-904-0370

Parent Company Information

Idorsia Pharmaceuticals Ltd
- Hegenheimermattweg 91
  Allschwil 4123
  Switzerland

Subsidiary Beneficiary Information

Idorsia Pharmaceuticals Canada Ltd does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Ron Morcos, General Manager Canada | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Idorsia Pharmaceuticals Canada Ltd/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Idorsia Pharmaceuticals Canada Ltd/	2024-04-03	current

Idorsia Pharmaceuticals Canada Ltd

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Ron Morcos, General Manager Canada (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-11 of 11

Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Luc Theriault, Member of Parliament | House of Commons
Subject Matter of the communication: Budget, Health, Industry, Research and Development, Science and Technology, Small Business
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601391 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Frances McRae, Deputy Minister | Women and Gender Equality (WAGE)
Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology, Small Business
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601390 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Felipe Alfaro, Policy Advisor | Minister of Labour and Seniors | House of Commons
Subject Matter of the communication: Economic Development, Health, Labour, Science and Technology, Small Business, Transportation
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601389 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Patrick Mangan, Policy Advisor and Parliamentary Secretary Assistant | Agriculture and Agri-Food Canada (AAFC)
Subject Matter of the communication: Economic Development, Health, Industry, International Trade, Labour, Research and Development, Science and Technology, Small Business, Agriculture, Employment and Training
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601388 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Élisabeth Brière, Parliamentary Secretary | Mental Health and Addictions and Families Children and Social Development | Health Canada (HC)
- Abdel Amin, Special Assistant | Parliamentary affairs and issues management | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Small Business, Employment and Training
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601387 (amended from 377646-601385) View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Richard Bragdon, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Small Business, Aboriginal Affairs
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601386 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Judy Sgro, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Science and Technology, Small Business
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601384 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kelly McCauley, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Science and Technology, Small Business
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601383 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mohamed-Iqbal Ravalia, Senator | Senate of Canada
Subject Matter of the communication: Economic Development, Health, Science and Technology, Small Business, Employment and Training
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601382 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Doug Shipley, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Labour, Science and Technology, Small Business
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601380 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ruby Sahota, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Science and Technology, Small Business, Employment and Training
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601379 View associated registration

Ron Morcos, General Manager Canada (Corporation)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-11 of 11

Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Luc Theriault, Member of Parliament | House of Commons
Subject Matter of the communication: Budget, Health, Industry, Research and Development, Science and Technology, Small Business
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601391 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Frances McRae, Deputy Minister | Women and Gender Equality (WAGE)
Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology, Small Business
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601390 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Felipe Alfaro, Policy Advisor | Minister of Labour and Seniors | House of Commons
Subject Matter of the communication: Economic Development, Health, Labour, Science and Technology, Small Business, Transportation
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601389 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Patrick Mangan, Policy Advisor and Parliamentary Secretary Assistant | Agriculture and Agri-Food Canada (AAFC)
Subject Matter of the communication: Economic Development, Health, Industry, International Trade, Labour, Research and Development, Science and Technology, Small Business, Agriculture, Employment and Training
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601388 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Élisabeth Brière, Parliamentary Secretary | Mental Health and Addictions and Families Children and Social Development | Health Canada (HC)
- Abdel Amin, Special Assistant | Parliamentary affairs and issues management | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Small Business, Employment and Training
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601387 (amended from 377646-601385) View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Richard Bragdon, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Small Business, Aboriginal Affairs
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601386 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Judy Sgro, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Science and Technology, Small Business
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601384 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kelly McCauley, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Science and Technology, Small Business
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601383 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mohamed-Iqbal Ravalia, Senator | Senate of Canada
Subject Matter of the communication: Economic Development, Health, Science and Technology, Small Business, Employment and Training
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601382 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Doug Shipley, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Labour, Science and Technology, Small Business
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601380 View associated registration
Idorsia Pharmaceuticals Canada Ltd
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ruby Sahota, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Science and Technology, Small Business, Employment and Training
Communication date: 2024-04-09
Posted date: 2024-05-15
Communication number: 377646-601379 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Idorsia Pharmaceuticals Canada Ltd / Ron Morcos, General Manager Canada

Registration Information

Associated Communications

Version 1 of 1 (2024-04-03 to present)

Version 1 of 1 (2024-04-03 to present)

Subject Matter Details

Subject matters added through a monthly communication report

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties